Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial
Fig 1
Flowchart.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Flowchart.